Vaccine and Drug Delivery Systems
Vaccine is a material which induces an immunologically mediated resistance to a disease but not necessarily an infection. Vaccines or antigens are generally composed of killed or attenuated organisms or subunits of organisms or DNA encoding antigenic proteins of pathogens. Sub-unit vaccines though they are exceptionally selective and specific in reacting with antibodies often fail to show such reactions in some circumstances such as shifts in epitopic identification center of antibody and are poorly immunogenic. Delivery of antigens or vaccine from oil-based adjuvants like Freunds adjuvant lead to a reduction in the number of doses of vaccine to be administered but due to the toxicity concerns such as inductions of granulomas at the injection site and are not widely used. FDA approved adjuvants for human uses are aluminium hydroxide and aluminium phosphate in the form of alum.
Related Conference of Vaccine and Drug Delivery Systems
17th International Conference on Tissue Science and Regenerative Medicine
Vaccine and Drug Delivery Systems Conference Speakers
Recommended Sessions
- Chemoinformatic Drug Discovery
- Clinical Trials and Regulatory Affairs in Pharmacy
- Computer Aided Drug Designing
- Corona Virus Drug Discovery
- Drug Chemistry
- Medical Devices for Drug Delivery
- Molecular Modelling in Drug Designing
- New Trends in Pharmacology and Drug Development
- Proteomics & Bioinformatics Drug Discovery
- Vaccine and Drug Delivery Systems
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- 3D Structure Determination - Structural Biology-2025 (France)
- Advanced Techniques in Structural Biology - Structural Biology-2025 (France)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- AI & Computational Structural Biology - Structural Biology-2025 (France)
- Biochemistry and Biophysics - Structural Biology-2025 (France)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology-2025 (France)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology-2025 (France)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene Regulation and Cell Signaling - Structural Biology 2025 (Germany)
- Hybrid Approaches for Structure Prediction - Structural Biology-2025 (France)
- Hybrid Approaches in Structure Prediction - Structural Biology 2025 (Germany)
- Membrane Proteins and Receptors - Structural Biology-2025 (France)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular Biology Techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology-2025 (France)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Proteomics and Genomics - Structural Biology-2025 (France)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Bioinformatics and Computational Biology - Structural Biology-2025 (France)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology-2025 (France)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)
- Structural Virology - Structural Biology-2025 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2025 (France)
- Structure-Based Drug Discovery - Structural Biology-2025 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2025 (France)
- Structure-Function Relationships - Structural Biology-2025 (France)
- The Structural Basis of Disease - Structural Biology-2025 (France)